(Q36086429)

12 August 2017

1 reference

title

Do preclinical testing strategies help predict human hepatotoxic potentials? (English)

1 reference

12 August 2017

1 reference

Terry S Peters

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

published in

Toxicologic Pathology

1 reference

12 August 2017

volume

33

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

146-154

1 reference

Criteria of drug-induced liver disorders. Report of an international consensus meeting

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Idiosyncratic drug hepatotoxicity revisited: new insights from mechanistic toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

21 January 2018

Antibiotic side effects

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Nephrotoxic and hepatotoxic potential of imidazolidinedione-, oxazolidinedione- and thiazolidinedione-containing analogues of N-(3,5-dichlorophenyl)succinimide (NDPS) in Fischer 344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Acute Liver Failure in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Telithromycin: the first of the ketolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Thiazolidinediones -- some recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Hepatotoxicity of antibiotics and antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Drug intolerance to high-dose clarithromycin among elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230590522121

10.1080/01926230590522121

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference